Moderna, Inc. (MRNA)
47.95
+0.92
(+1.96%)
USD |
NASDAQ |
May 27, 11:58
Moderna Free Cash Flow : -1.603B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Gilead Sciences, Inc. | 10.23B |
| Arbutus Biopharma Corp. | -34.44M |
| Biogen, Inc. | 2.316B |
| AbbVie, Inc. | 19.98B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -630.00M |
| Cash from Investing (Quarterly) | -76.00M |
| Cash from Financing (Quarterly) | 17.00M |
| Free Cash Flow Per Share (Quarterly) | -1.752 |
| Free Cash Flow to Equity (Quarterly) | -685.00M |
| Free Cash Flow to Firm (Quarterly) | -674.89M |
| Free Cash Flow Yield | -8.54% |